Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.3. Other antivirals |
Outras observações: Severe illness due to confirmed or suspected influenza virus infection in critically ill hospitalized patients. |
Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.3. Other antivirals |
Outras observações: Severe illness due to confirmed or suspected influenza virus infection in critically ill hospitalized patients. |
Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.3. Other antivirals |
Outras observações: Severe illness due to confirmed or suspected influenza virus infection in critically ill hospitalized patients. |
Cuba | 6.4 Antivirales | Sem observações |
Listas | Seção | Observação |
---|---|---|
Cuba | 6.4 Antivirales | Sem observações |
Listas | Seção | Observação |
---|---|---|
PAHO Strategic Fund Medicine List | 2.6.2. Other Antivirals |
Outras observações: According to the 20th World Health Organization Model List of Essential Medicines published in March 2017, Oseltamivir is indicated for severe illness due to confirmed or suspected influenza virus infection in critically ill hospitalized patients. |
Listas | Seção | Observação |
---|---|---|
PAHO Strategic Fund Medicine List | 2.6.2. Other Antivirals |
Outras observações: According to the 20th World Health Organization Model List of Essential Medicines published in March 2017, Oseltamivir is indicated for severe illness due to confirmed or suspected influenza virus infection in critically ill hospitalized patients. |